Holland R, Hendriks J H, Vebeek A L, Mravunac M, Schuurmans Stekhoven J H
Department of Pathology, Radboud University Hospital, Nijmegen, The Netherlands.
Lancet. 1990 Mar 3;335(8688):519-22. doi: 10.1016/0140-6736(90)90747-s.
To assess the potential of breast-conserving treatment for ductal carcinoma in situ (DCIS), 82 mastectomy specimens were studied by Egan's serial subgross method. 42 (51%) of the tumours were larger than 50 mm and only 12 (15%) were smaller than 20 mm; the size distribution was not affected by the mode of detection (mammography 52 cases, clinical examination 30). All but 1 case showed only 1 region of tumour. 66% of tumours involved one breast quadrant, 23% extended over more than one quadrant, and 11% were centrally located. Mammographic estimates, based on the extent of microcalcifications, frequently underestimated the histological size of tumours, the extent of the discrepancy being related to the histological type--8/50 predominantly micropapillary/cribriform. In view of the frequently large size, adequate excision of many DCIS will require a wide excision involving up to a whole quadrant.
为评估保乳治疗导管原位癌(DCIS)的潜力,采用伊根连续大体下方法对82例乳房切除术标本进行了研究。42例(51%)肿瘤大于50mm,仅12例(15%)小于20mm;肿瘤大小分布不受检测方式影响(乳腺钼靶检查52例,临床检查30例)。除1例以外,所有病例均仅显示1个肿瘤区域。66%的肿瘤累及一个乳腺象限,23%扩展至一个以上象限,11%位于中央。基于微钙化范围的乳腺钼靶估计常常低估肿瘤的组织学大小,差异程度与组织学类型有关——50例中8例主要为微乳头/筛状型。鉴于肿瘤常常较大,许多DCIS的充分切除需要广泛切除,累及多达整个象限。